Oncology
Focus oncology development on the patient, manage trial complexity, and increase predictability and speed.
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Public Health and Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSFEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience powered by Apple
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions powered by Apple
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSBlog
AI vs. Rare Disease:
How human ingenuity and data science can improve disease detection
Feb 28, 2020
Today, there are approximately 350 million people living with 7,000 rare diseases worldwide. In the United States alone, 25 to 30 million people are affected – more than half of whom are children – while treatments are available for just 5% of them. As these diseases are exceedingly rare, initial misdiagnosis is common and underdiagnosis is extensive. On average, it can take more than seven years for patients with a rare disease to receive an accurate diagnosis – which creates a significant delay to critical treatment options for these patients.
We must find a more reliable means of detecting rare diseases to ensure patients get the treatments they need. With advances in machine learning and deep learning technologies, we can now begin to pursue answers to questions about these diseases regardless of the complexity in faster, more compelling ways.
Two primary challenges exist in using machine learning to detect rare diseases. First, the low prevalence rates of these diseases limit the number of positive subjects in the training data (i.e., patients with a confirmed diagnosis of a disease). Thus, disease patterns are hard to extract.
This is made more difficult by the fact that many rare diseases have not been assigned an ICD-10 code. ICD-10 codes are used by physicians to identify specific diseases or symptoms. In the case of many rare diseases, each physician must use their judgment to select an ICD-10 code that best accounts for a patient’s symptoms. In practice, this means a set of patients who in fact share the same disease could each be assigned a different ICD-10 code.
Second, there are many patients with an uncertain diagnosis due to the long period needed for rare diseases to be correctly diagnosed. Although we do not know who those patients are, their existence can potentially help. In recent years, the availability of massive electronic health records (EHR) data has further enabled the training of deep learning models for accurate predictive health.
Getting past the false positive hurdle
While artificial intelligence holds great promise for detecting undiagnosed patients, the barrier is much higher with rare diseases due to the difficulty in distinguishing between patients with similar conditions due to the low prevalence rates of rare diseases. To tackle these challenges, we need to continue to evolve how we apply machine learning. One way is to use pattern augmentation to better preserve and enrich crucial patterns of the target disease.
In partnership with Jimeng Sun, University of Illinois Urbana-Champaign, my team at IQVIA published a paper featured at AAAI 2020 outlining a Complementary Pattern Augmentation (CONAN) framework for rare and low prevalence disease detection.
CONAN uses the idea of adversarial learning. First, a generator learns to create plausible, but fake, patient samples. Then, a disease detector aims to distinguish between negative and positive patient samples. This establishes what is called a minimax game between the generator and disease detector. After this training, the disease detector can be used for detecting positive patients. Experiments on real-world data sets demonstrated strong performance. Read the full paper here.
Improving the ability to detect rare diseases is a critical step in finding answers to the perplexing questions surrounding rare diseases, and ultimately ensuring patients can be properly diagnosed and treated. To build on this success, deep expertise and creativity are required to challenge the way things have been done previously and to make connections, with accuracy, even when it seems impossible.
At IQVIA, we believe the pursuit of a healthier world begins by solving problems that once seemed unsolvable and enabling treatments for diseases once thought untreatable. In this pursuit, Human Data Science leads the way. It’s a revolutionary way to approach problem solving in healthcare, harnessing advances in technology, data science and human ingenuity to improve human health.
For more information on rare diseases and orphan drugs read the IQVIA Institute report.
Related solutions
Therapeutic & Specialty Expertise
Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.